Mylan says court dismisses some of Teva's patent claims on MS drug

[riky]

Mylan says court dismisses some of Teva's patent claims on MS drug

(Reuters) - A federal court in New York ruled that Mylan Inc's generic application for a multiple sclerosis drug has not infringed some of Teva Pharmaceutical Industries' patents, Mylan said. Israel-based Teva is also suing Momenta Pharmaceuticals, Novartis AG's Sandoz unit and India-based Natco Pharmaceuticals for infringing patents on its drug, Copaxone. A federal court had upheld another bunch of Teva's patents on the same drug in June but Mylan is appealing the ruling. "The patents in question in today's decision are different than those involved in the appeal. ...

Source: You are not allowed to view links. Register or Login